These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38386185)

  • 1. Blinded by Stress: A Patient and Physician Perspective on Central Serous Chorioretinopathy.
    Mark J; Subhi Y
    Ophthalmol Ther; 2024 Apr; 13(4):861-866. PubMed ID: 38386185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central serous chorioretinopathy.
    Marcuson J; Riley T
    Optometry; 2008 May; 79(5):241-51. PubMed ID: 18436164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multimodal Imaging in Fibrinous Central Serous Chorioretinopathy Compared with Exudative Maculopathy.
    Lyu Y; Li X; Gong Y
    Ophthalmologica; 2020; 243(5):360-369. PubMed ID: 32008002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Half-dose verteporfin photodynamic therapy for bullous variant of central serous chorioretinopathy: a case report.
    Ng WW; Wu ZH; Lai TY
    J Med Case Rep; 2011 May; 5():208. PubMed ID: 21615893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stress and vision-related quality of life in acute and chronic central serous chorioretinopathy.
    Kumar M; van Dijk EHC; Raman R; Mehta P; Boon CJF; Goud A; Bharani S; Chhablani J
    BMC Ophthalmol; 2020 Mar; 20(1):90. PubMed ID: 32143668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PRESENTATION OF CENTRAL SEROUS CHORIORETINOPATHY IN TWO HUSBAND AND WIFE COUPLES.
    Kanesa-Thasan A; Fawzi AA; Gill MK
    Retin Cases Brief Rep; 2018 Spring; 12(2):100-102. PubMed ID: 29554052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photodynamic therapy and central serous chorioretinopathy.
    Siaudvytyte L; Diliene V; Miniauskiene G; Balciuniene VJ
    Med Hypothesis Discov Innov Ophthalmol; 2012; 1(4):67-71. PubMed ID: 24600627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exacerbation of central serous chorioretinopathy during trauma-confronting psychotherapy- a case report.
    Schäflein E; Mardin C; Morawa E; Rudolf S; Erim Y; Rhein C
    BMC Psychiatry; 2024 May; 24(1):368. PubMed ID: 38755608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment and Monitoring of Central Serous Chorioretinopathy in Pilots.
    Shinojima A; Mori R; Fujita K; Yuzawa M
    Aerosp Med Hum Perform; 2016 Dec; 87(12):1041-1044. PubMed ID: 28323591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of Central Serous Chorioretinopathy: Clinical Presentation and Management.
    Varghese J; Kesharwani D; Parashar S; Agrawal P
    Cureus; 2022 Aug; 14(8):e27965. PubMed ID: 36120212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choroidal effusion as a manifestation of central serous chorioretinopathy: A case report.
    Tran T; Okada M; Goh J; Gin T; Harper CA
    Am J Ophthalmol Case Rep; 2022 Mar; 25():101311. PubMed ID: 35146193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Reduced-fluence Photodynamic Therapy for Chronic Central Serous Chorioretinopathy: A Propensity Score Analysis.
    Aisu N; Miyake M; Hosoda Y; Mori Y; Takahashi A; Muraoka Y; Ueda-Arakawa N; Miyata M; Oishi A; Tamura H; Ooto S; Yamashiro K; Tsujikawa A
    Ophthalmol Sci; 2022 Jun; 2(2):100152. PubMed ID: 36249695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
    Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. One-year choroidal thickness results after photodynamic therapy for central serous chorioretinopathy.
    Maruko I; Iida T; Sugano Y; Furuta M; Sekiryu T
    Retina; 2011 Oct; 31(9):1921-7. PubMed ID: 21878850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Genetic Background of Central Serous Chorioretinopathy: A Review on Central Serous Chorioretinopathy Genes.
    Giannopoulos K; Gazouli M; Chatzistefanou K; Bakouli A; Moschos MM
    J Genomics; 2021; 9():10-19. PubMed ID: 33456587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fighter Pilot with Recurrent Central Serous Chorioretinopathy.
    Dietrich KC
    Aerosp Med Hum Perform; 2016; 87(10):901-905. PubMed ID: 27662355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of Central Serous Chorioretinopathy: A Review of the Current Treatments.
    Iacono P; Toto L; Costanzo E; Varano M; Parravano MC
    Curr Pharm Des; 2018; 24(41):4864-4873. PubMed ID: 30674250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bullous Central Serous Chorioretinopathy: A Rare and Atypical Form of Central Serous Chorioretinopathy. A Systematic Review.
    Sartini F; Menchini M; Posarelli C; Casini G; Figus M
    Pharmaceuticals (Basel); 2020 Aug; 13(9):. PubMed ID: 32872388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Photodynamic therapy in a patient with chronic central serous chorioretinopathy--a case report].
    Pociej W; Karska-Basta I; Kolár L; Oleksy P; Romanowska-Dixon B
    Klin Oczna; 2014; 116(1):28-31. PubMed ID: 25137918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and associations of central serous chorioretinopathy in elderly Chinese. The Beijing Eye Study 2011.
    Li Y; You QS; Wei WB; Xu J; Chen CX; Wang YX; Xu L; Jonas JB
    Acta Ophthalmol; 2016 Jun; 94(4):386-90. PubMed ID: 26928876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.